- 24/7 Wall St.•2 days ago
Not that many biotech and pharma companies were on the move Thursday, just one day before the inauguration. However, a few of the smaller caps made splash.
- Zacks•2 days ago
Apricus (APRI) announced that Vitaros was approved in Mexico for the treatment of patients with erectile dysfunction.
- 24/7 Wall St.•3 days ago
The biotechs and emerging pharma have been under pressure from politicians attacking drug prices. That doesn't mean that there are not some big winners out there.
APRI : Summary for Apricus Biosciences, Inc. - Yahoo Finance
Apricus Biosciences, Inc. (APRI)
NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Add to watchlist
|Bid||2.10 x 10000|
|Ask||2.99 x 3000|
|Day's Range||2.11 - 2.83|
|52 Week Range||0.26 - 4.07|
Trade prices are not sourced from all markets
|PE Ratio (TTM)||-1.68|
|Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|